This raises the question whether the stemness score, which has been trained on adult AML, is useful to predict prognosis of pediatric patients particularly considering that large subtypes of adult AML such as APL and AML with mutated NPM1 are rare in pediatric AML. The gene discussed is NPM1; the disease is acute myeloid leukemia.